INOVIO PHARMACEUTICALS, INC. Accrued Liabilities, Current
INOVIO PHARMACEUTICALS, INC. (INO) had Accrued Liabilities, Current of $4.50 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2019-11-12
- 2019-09-30: Accrued Liabilities, Current $4.50M.
- 2019-06-30: Accrued Liabilities, Current $4.64M.
- 2019-03-31: Accrued Liabilities, Current $7.16M.
- 2018-12-31: Accrued Liabilities, Current $5.67M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2019-09-30 | $4.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.64M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.16M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.67M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $7.35M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $10.36M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $8.43M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $8.61M 10-K · filed 2019-03-12 |
| 2017-09-30 | $7.92M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $7.19M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $5.91M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $6.37M 10-K · filed 2018-03-14 |
| 2016-09-30 | $7.22M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.01M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $4.15M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.60M 10-K · filed 2017-03-15 |
| 2015-09-30 | $2.94M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.55M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.27M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.01M 10-K · filed 2016-03-14 |
| 2014-09-30 | $1.26M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.72M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.74M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.45M 10-K · filed 2015-03-16 |
| 2013-09-30 | $1.36M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.73M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $2.20M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.41M 10-K · filed 2014-03-17 |
| 2012-09-30 | $1.38M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $1.16M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $773.77K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $1.06M 10-K · filed 2013-03-18 |
| 2011-09-30 | $817.60K 10-Q · filed 2011-11-07 |
| 2011-06-30 | $426.47K 10-Q · filed 2011-08-05 |
| 2010-12-31 | $178.33K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |